Ken Griffin Merck & Co., Inc. Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $44.1 Million - $51.4 Million	389,400 Added 29.07%	1,729,000 $228 Million
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $25.7 Million - $28 Million	-256,800 Reduced 16.09%	1,339,600 $146 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $3.44 Million - $3.82 Million	-33,400 Reduced 2.05%	1,596,400 $164 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $86.7 Million - $94.5 Million	-797,900 Reduced 32.87%	1,629,800 $188 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $191 Million - $213 Million	-1,857,400 Reduced 43.35%	2,427,700 $258 Million

Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $187 Million - $239 Million	2,135,800 Added 99.37%	4,285,100 $475 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $8.82 Million - $9.9 Million	-104,300 Reduced 4.63%	2,149,300 $185 Million

3,766

1.87B

17.3M

14.8M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $314B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.